Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Zillow Group Inc Class A — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $296.08 (market cap $8.04B), while Zillow Group Inc Class A trades at $33.8 (market cap $7.28B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock and Zillow Group Inc Class A are close in size by market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals.
| BIO | ZG | |
|---|---|---|
Market Cap | $8.04B | $7.28B |
Sector | Health | Media |
52-Week High | $339.75 | $86.76 |
52-Week Low | $241.71 | $29.14 |
Enterprise Value | $7.85B | $6.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (ZG) trades at $31.94, down 0.19% with a bearish technical signal. The company shows improving fundamentals with revenue growth to $2.58B in 2025 and a return to profitability with $23M net income. Analyst consensus remains positive with a $57.80 price target, though recent securities class action lawsuits create near-term uncertainty. Technical indicators show the stock trading near support at $31 with resistance at $33.
ZG presents a mixed outlook with strong analyst support but significant legal overhangs. The company's turnaround to profitability and 51% buy rating suggest upside potential, but ongoing litigation regarding anticompetitive practices with Redfin poses substantial risk. Investors should weigh improving fundamentals against regulatory and legal challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
